{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:29:49Z","timestamp":1785796189096,"version":"3.56.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,6]],"date-time":"2014-08-06T00:00:00Z","timestamp":1407283200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12929-014-0074-2","type":"journal-article","created":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T10:20:01Z","timestamp":1407234001000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Neuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylation"],"prefix":"10.1186","volume":"21","author":[{"given":"Rita U","family":"Ostrovskaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia V","family":"Vakhitova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uliyana Sh","family":"Kuzmina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milyausha Kh","family":"Salimgareeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana F","family":"Zainullina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana A","family":"Gudasheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vener A","family":"Vakhitov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey B","family":"Seredenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,6]]},"reference":[{"key":"74_CR1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jalz.2011.02.002","volume":"7","author":"W Thies","year":"2011","unstructured":"Thies W, Bleiler L: Alzheimer\u2019s Association, 2011 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2011, 7: 208-244.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"74_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2012.236","volume":"9","author":"D Krstic","year":"2013","unstructured":"Krstic D, Knuesel I: Deciphering the mechanism underlying late-onset Alzheimer disease. Nat Rev Neurol. 2013, 9 (1): 25-34.","journal-title":"Nat Rev Neurol"},{"key":"74_CR3","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archneurol.2011.69","volume":"68","author":"LS Schneider","year":"2011","unstructured":"Schneider LS, Dagerman KS, Higgins JP, McShane R: Lack of evidence for the efficacy of memantine in mild Alzheimer Disease. Arch Neurol. 2011, 68: 991-998.","journal-title":"Arch Neurol"},{"issue":"7","key":"74_CR4","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1474-4422(10)70119-8","volume":"9","author":"F Mangialasche","year":"2010","unstructured":"Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M: Alzheimer\u2019s disease: clinical trials and drug development. Lancet Neurol. 2010, 9 (7): 702-716.","journal-title":"Lancet Neurol"},{"key":"74_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1602\/neurorx.1.1.117","volume":"1","author":"FM Longo","year":"2004","unstructured":"Longo FM, Massa SM: Neuroprotective strategies in Alzheimer\u2019s Disease. NeuroRx. 2004, 1: 117-127.","journal-title":"NeuroRx"},{"key":"74_CR6","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1517\/14728210903257796","volume":"14","author":"JJ Buccafusco","year":"2009","unstructured":"Buccafusco JJ: Emerging cognitive enhancing drugs. Expert Opin Emerg Drugs. 2009, 14: 577-589.","journal-title":"Expert Opin Emerg Drugs"},{"key":"74_CR7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s12035-010-8137-1","volume":"41","author":"SA Frautschy","year":"2010","unstructured":"Frautschy SA, Cole GM: Why pleiotropic interventions are needed for Alzheimer\u2019s Disease. Mol Neurobiol. 2010, 41: 392-409.","journal-title":"Mol Neurobiol"},{"key":"74_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1152\/physiol.00022.2006","volume":"21","author":"O Kaidanovich","year":"2006","unstructured":"Kaidanovich O, Eldar-Finkelman H: Peptides targeting protein kinases: strategies implications. Physiology. 2006, 21: 411-418.","journal-title":"Physiology"},{"key":"74_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1113\/jphysiol.2006.107904","volume":"574","author":"M Sala-Rabanai","year":"2006","unstructured":"Sala-Rabanai M, Loo DDT, Hirayama BA, Turk E, Wright EMJ: Molecular interactions between dipeptides, drugs and the human intenstinal H+ oligopeptide cotransporter hPEPT 1. J Physiol. 2006, 574: 149-166.","journal-title":"J Physiol"},{"key":"74_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0223-5234(96)80448-X","volume":"31","author":"TA Gudasheva","year":"1996","unstructured":"Gudasheva TA, Voronina TA, Ostrovskaya RU, Rozantsev GG, Vasilevich NI, Trofimov SS, Kravchenko EV, Skoldinov AP, Seredenin SB: Synthesis and antimnestetic activity of a series of N-acylprolyl-containing dipeptides. Eur J Med Chem. 1996, 31: 151-157.","journal-title":"Eur J Med Chem"},{"key":"74_CR11","unstructured":"Seredenin SB, Voronina TA, Gudasheva TA, Ostrovskaya RU, Rozantsev GG, Skoldinov AP, Trofimov SS, Halikas J, Garibova TL: Biologically active N-acylprolyldipeptides having antiamnestic, antihypoxic effects.US patent 1995. No. 5.439.930.,"},{"key":"74_CR12","first-page":"79","volume-title":"Biological Basis of Individual Sensitivity to Psychotropic Drugs","author":"RU Ostrovskaya","year":"1994","unstructured":"Ostrovskaya RU, Gudasheva TA, Trofimov SS, Kravchenko EV, Firova FV, Molodavkin GM, Voronina TA, Seredenin SB: GVS-111, an Acylprolyl-Containing Dipeptide With Nootropic Properties. Biological Basis of Individual Sensitivity to Psychotropic Drugs. Edited by: Seredenin SB, Longo V, Gaviraghi G. 1994, Graffhan Press Ltd, UK, 79-91."},{"key":"74_CR13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/BF02439270","volume":"129","author":"SS Boiko","year":"2000","unstructured":"Boiko SS, Ostrovskaya RU, Zherdev VP, Korotkov SA, Gudasheva TA, Voronina TA, Seredenin SB: Pharmacokinetics of new nootropic acylprolyldipeptide and its penetration across the blood\u2013brain barrier after oral administration. Bull Exp Biol Med. 2000, 129: 359-361.","journal-title":"Bull Exp Biol Med"},{"key":"74_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/BF03189814","volume":"22","author":"TA Gudasheva","year":"1997","unstructured":"Gudasheva TA, Bojko SS, Voronina TA, Akparov VK, Trofimov SS, Rozantsev GG, Skoldinov AP, Zherdev VP, Seredenin SB: The major metabolite of dipeptide piracetam analogue GVS-111 in rat brain and its similarity to endogenous neuropeptide cyclo-L-prolylglycine. Eur J Drug Metab Pharmacokinet. 1997, 22: 245-252.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"74_CR15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/00008877-199909000-00013","volume":"10","author":"RU Ostrovskaya","year":"1999","unstructured":"Ostrovskaya RU, Romanova GA, Barskov IV, Shanina EV, Gudasheva TA, Victorov IV, Voronina TA, Seredenin SB: Memory restoring and neuroprotective effects of the proline containing dipeptide, GVS-111, in a photochemical stroke model. Behav Pharmacol. 1999, 10: 549-553.","journal-title":"Behav Pharmacol"},{"key":"74_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0736-5748(03)00031-5","volume":"21","author":"A Pealsman","year":"2003","unstructured":"Pealsman A, Hoyo-Vadillo C, Seredenin SB, Gudasheva TA, Ostrovskaya RU, Busciglio J: GVS-111 prevents oxidative damage and apoptosis in normal and Down\u2019s syndrome human cortical neurons. Int J Dev Neurosci. 2003, 21: 117-124.","journal-title":"Int J Dev Neurosci"},{"issue":"5","key":"74_CR17","first-page":"66","volume":"65","author":"RU Ostrovskaia","year":"2002","unstructured":"Ostrovskaia RU, Gudasheva TA, Voronina TA, Seredenin SB: The original novel nootropic and neuroprotective agent Noopept. Eksp Klin Farmakol. 2002, 65 (5): 66-72.","journal-title":"Eksp Klin Farmakol"},{"key":"74_CR18","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1177\/0269881106071335","volume":"21","author":"RU Ostrovskaya","year":"2007","unstructured":"Ostrovskaya RU, Gruden MA, Bobkova NA, Sewell RDE, Gudasheva TA, Samokhin AN, Seredenin SB, Noppe W, Sherstnev VV, Morozova-Roche LA: The nootropic and neuroprotective proline-containing dipeptide Noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer\u2019s Disease model. J Psychopharmacol. 2007, 21: 611-619.","journal-title":"J Psychopharmacol"},{"key":"74_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10517-008-0211-6","volume":"146","author":"RU Ostrovskaya","year":"2008","unstructured":"Ostrovskaya RU, Belnik AP, Storozheva ZI: Noopept efficiency in experimental Alzheimer Disease (cognitive deficiency caused by beta-amyloid 25\u201335 injection into Meynert basal nuclei of rats). Bull Exp Biol Med. 2008, 146: 77-80.","journal-title":"Bull Exp Biol Med"},{"key":"74_CR20","first-page":"2","volume":"73","author":"RU Ostrovskaya","year":"2010","unstructured":"Ostrovskaya RU, Tsaplina AP, Vakhitova YV, Salimgareeva MK, Yamidanov RS: Effect of the novel cognition enhancing and neuroprotective dipeptide Noopept on the streptozotocin-induced model of sporadic Alzheimer Disease in rats. Eksp Klin Farmakol. 2010, 73: 2-6.","journal-title":"Eksp Klin Farmakol"},{"issue":"3","key":"74_CR21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s11055-009-9128-4","volume":"39","author":"GG Neznamov","year":"2009","unstructured":"Neznamov GG, Teleshova ES: Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin. Neurosci Behav Physiol. 2009, 39 (3): 311-321.","journal-title":"Neurosci Behav Physiol"},{"key":"74_CR22","first-page":"27","volume":"1","author":"SI Gavrilova","year":"2008","unstructured":"Gavrilova SI, Kolihalov IV, Fedorova JB, Kaljn JB, Selezneva ND: Expirience of Noopept clinical usage in the treatment of mild cognitive impairment syndrome. Modern Therapie of Psychiatric Disorders. 2008, 1: 27-32.","journal-title":"Modern Therapie of Psychiatric Disorders"},{"issue":"Pt 1","key":"74_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3110001","volume":"311","author":"LL Iversen","year":"1995","unstructured":"Iversen LL, Mortishire-Smith RJ, Pollack SJ, Shearman MS: The toxicity in vitro of beta-amyloid protein. Biochem J. 1995, 311 (Pt 1): 1-16.","journal-title":"Biochem J"},{"key":"74_CR24","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jmb.2011.09.044","volume":"414","author":"X Jia","year":"2011","unstructured":"Jia X, Gharibyan AL, \u00d6hman A, Liu Y, Olofsson A, Morozova-Roche LA: Neuroprotective and nootropic drug Noopept rescues \u03b1-synuclein amyloid cytotoxicity. J Mol Biol. 2011, 414: 699-712.","journal-title":"J Mol Biol"},{"issue":"3","key":"74_CR25","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1023\/B:NERE.0000014834.06405.af","volume":"29","author":"L Canevari","year":"2004","unstructured":"Canevari L, Abramov AY, Duchen MR: Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress. Neurochem Res. 2004, 29 (3): 637-650.","journal-title":"Neurochem Res"},{"key":"74_CR26","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/j.1471-4159.2010.06643.x","volume":"113","author":"AG Henriques","year":"2010","unstructured":"Henriques AG, Vieira SI, Da Cruz e Silva EF, Da Cruz e Silva OAB: A\u03b2 promotes Alzheimer\u2019s disease-like cytoskeleton abnormalities with consequences to APP processing in neurons. J Neurochem. 2010, 113: 761-771.","journal-title":"J Neurochem"},{"issue":"4","key":"74_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1515\/REVNEURO.2004.15.4.267","volume":"15","author":"TL Spires","year":"2004","unstructured":"Spires TL, Hyman BT: Neuronal structure is altered by amyloid plaques. Rev Neurosci. 2004, 15 (4): 267-278.","journal-title":"Rev Neurosci"},{"issue":"3","key":"74_CR28","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1046\/j.1471-4159.2000.741122.x","volume":"74","author":"RB Postuma","year":"2000","unstructured":"Postuma RB, He W, Nunan J, Beyreuther K, Masters CL, Barrow CJ, Small DH: Substrate-bound beta-amyloid peptides inhibit cell adhesion and neurite outgrowth in primary neuronal cultures. J Neurochem. 2000, 74 (3): 1122-1130.","journal-title":"J Neurochem"},{"key":"74_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0306-3623(96)00529-0","volume":"29","author":"EI Solntseva","year":"1997","unstructured":"Solntseva EI, Bukanova JV, Ostrovskaya RU, Gudasheva TA, Voronina TA, Skrebitsky VG: The effects of piracetam and its novel peptide analogue GVS-111 on neuronal voltage-gated calcium and potassium channels. Gen Pharmacol. 1997, 29: 85-89.","journal-title":"Gen Pharmacol"},{"key":"74_CR30","first-page":"418","volume":"130","author":"NA Andreeva","year":"2000","unstructured":"Andreeva NA, Stel\u2019mashuk EV, Isaev NK, Ostrovskaya RU, Gudasheva TA, Viktorov IV: Neuroprotective effects of nootropic dipeptide GVS-111 on the model of glucose-oxygen deprivation, glutamate toxicity and oxidative stress in vitro. Bull Exp Biol Med. 2000, 130: 418-421.","journal-title":"Bull Exp Biol Med"},{"key":"74_CR31","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1134\/S1819712407020055","volume":"1","author":"KS Us","year":"2007","unstructured":"Us KS, Klodt PM, Kudrin VS, Sapronova AY, Ostrovskaya RU, Ugryumov MV, Rayevsky KS: The effect of the synthetic neuroprotective dipeptide Noopept on glutamate slices. J Neurochem. 2007, 1: 138-142.","journal-title":"J Neurochem"},{"issue":"8","key":"74_CR32","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2174\/156720510793611592","volume":"7","author":"K Iqbal","year":"2010","unstructured":"Iqbal K, Liu F, Gong CX, Grundke-Iqbal I: Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res. 2010, 7 (8): 656-664.","journal-title":"Curr Alzheimer Res"},{"issue":"Pt 4","key":"74_CR33","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1242\/jcs.107.4.869","volume":"107","author":"B Esmaeli-Azad","year":"1994","unstructured":"Esmaeli-Azad B, McCarty JH, Feinstein SC: Sense and antisense transfection analysis of tau function: tau influences net microtubule assembly, neurite outgrowth and neuritic stability. J Cell Sci. 1994, 107 (Pt 4): 869-879.","journal-title":"J Cell Sci"},{"issue":"5","key":"74_CR34","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1083\/jcb.150.5.989","volume":"150","author":"Y Takei","year":"2000","unstructured":"Takei Y, Teng J, Harada A, Hirokawa N: Defects in axonal elongation and neuronal migration in mice with disrupted tau and map1b genes. J Cell Biol. 2000, 150 (5): 989-1000.","journal-title":"J Cell Biol"},{"issue":"Suppl 1","key":"74_CR35","first-page":"S123","volume":"33","author":"JZ Wang","year":"2013","unstructured":"Wang JZ, Xia YY, Grundke-Iqbal I, Iqbal K: Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration. J Alzheimers Dis. 2013, 33 (Suppl 1): S123-S139.","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"74_CR36","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.1073\/pnas.91.12.5562","volume":"91","author":"AC Alonso","year":"1994","unstructured":"Alonso AC, Zaidi T, Grundke-Iqbal I, Iqbal K: Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci U S A. 1994, 91 (12): 5562-5566.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"74_CR37","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1091\/mbc.10.3.727","volume":"10","author":"J Biernat","year":"1999","unstructured":"Biernat J, Mandelkow EM: The development of cell processes induced by tau protein requires phosphorylation of serine 262 and 356 in the repeat domain and is inhibited by phosphorylation in the proline-rich domains. Mol Biol Cell. 1999, 10 (3): 727-740.","journal-title":"Mol Biol Cell"},{"key":"74_CR38","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/0896-6273(95)90232-5","volume":"14","author":"J Busciglio","year":"1995","unstructured":"Busciglio J, Lorenzo A, Yeh J, Yankner BA: \u03b2-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron. 1995, 14: 879-888.","journal-title":"Neuron"},{"issue":"6","key":"74_CR39","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/BF03033284","volume":"6","author":"J Avila","year":"2004","unstructured":"Avila J, P\u00e9rez M, Lim F, G\u00f3mez-Ramos A, Hern\u00e1ndez F, Lucas JJ: Tau in neurodegenerative diseases: tau phosphorylation and assembly. Neurotox Res. 2004, 6 (6): 477-482.","journal-title":"Neurotox Res"},{"key":"74_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1750-1326-4-13","volume":"4","author":"TF Gendron","year":"2009","unstructured":"Gendron TF, Petrucelli L: The role of tau in neurodegeneration. Mol Neurodegener. 2009, 4: 13-","journal-title":"Mol Neurodegener"},{"issue":"1","key":"74_CR41","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0306-4522(02)00404-9","volume":"115","author":"WH Zheng","year":"2002","unstructured":"Zheng WH, Bastianetto S, Mennicken F, Ma W, Kar S: Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures. Neuroscience. 2002, 115 (1): 201-211.","journal-title":"Neuroscience"},{"issue":"10","key":"74_CR42","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1091\/mbc.3.10.1141","volume":"3","author":"DN Drechsel","year":"1992","unstructured":"Drechsel DN, Hyman AA, Cobb MH, Kirschner MW: Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol Biol Cell. 1992, 3 (10): 1141-1154.","journal-title":"Mol Biol Cell"},{"key":"74_CR43","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/(SICI)1097-4547(19970115)47:2<216::AID-JNR10>3.0.CO;2-0","volume":"47","author":"O Salinero","year":"1997","unstructured":"Salinero O, Moreno-Flores MT, Ceballos ML, Wandosell F: beta-Amyloid peptide induced cytoskeletal reorganization in cultured astrocytes. Neurosci Res. 1997, 47: 216-223.","journal-title":"Neurosci Res"},{"issue":"9","key":"74_CR44","doi-asserted-by":"publisher","first-page":"6364","DOI":"10.1073\/pnas.092136199","volume":"99","author":"M Rapoport","year":"2002","unstructured":"Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A: Tau is essential to beta -amyloid-induced neurotoxicity. Proc Natl Acad Sci U S A. 2002, 99 (9): 6364-6369.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"74_CR45","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1073\/pnas.1017033108","volume":"108","author":"M Jin","year":"2011","unstructured":"Jin M, Shepardson N, Yang T, Chen G, Walsh D, Selkoe DJ: Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc Natl Acad Sci U S A. 2011, 108 (14): 5819-5824.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"74_CR46","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0168-0102(98)00061-3","volume":"31","author":"A Takashima","year":"1998","unstructured":"Takashima A, Honda T, Yasutake K, Michel G, Murayama O, Murayama M, Ishiguro K, Yamaguchi H: Activation of tau protein kinase I\/glycogen synthase kinase-3beta by amyloid beta peptide (25\u201335) enhances phosphorylation of tau in hippocampal neurons. Neurosci Res. 1998, 31 (4): 317-323.","journal-title":"Neurosci Res"},{"issue":"9","key":"74_CR47","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1097\/01.wnr.0000221844.35502.29","volume":"17","author":"S Johansson","year":"2006","unstructured":"Johansson S, J\u00e4ms\u00e4 A, Vas\u00e4nge M, Winblad B, Luthman J, Cowburn RF: Increased tau phosphorylation at the Ser396 epitope after amyloid beta-exposure in organotypic cultures. Neuroreport. 2006, 17 (9): 907-911.","journal-title":"Neuroreport"},{"key":"74_CR48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/B978-0-12-385114-7.00003-9","volume":"490","author":"K Shimoke","year":"2011","unstructured":"Shimoke K, Sasaya H, Ikeuchi T: Analysis of the role of nerve growth factor in promoting cell survival during endoplasmic reticulum stress in PC12 cells. Methods Enzymol. 2011, 490: 53-70.","journal-title":"Methods Enzymol"},{"key":"74_CR49","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.febslet.2004.04.047","volume":"566","author":"L Li","year":"2004","unstructured":"Li L, Sengupta A, Haque N, Grundke-Igbal I, Igbal K: Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration. FEBS Lett. 2004, 566: 261-269.","journal-title":"FEBS Lett"},{"key":"74_CR50","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.brainres.2007.03.051","volume":"1151","author":"M Hu","year":"2007","unstructured":"Hu M, Schurdak ME, Puttfarcken PS, El Kouhen R, Gopalakrishnan M, Li J: High content screen microscopy analysis of A beta 1-42-induced neurite outgrowth reduction in rat primary cortical neurons: neuroprotective effects of alpha 7 neuronal nicotinic acetylcholine receptor ligands. Brain Res. 2007, 1151: 227-235.","journal-title":"Brain Res"},{"key":"74_CR51","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.neuint.2010.07.007","volume":"57","author":"X Liu","year":"2010","unstructured":"Liu X, Xu K, Yan M, Wang Y, Zheng X: Protective effects of galantamine against Ab-induced PC12 cell apoptosis by preventing mitochondrial dysfunction and endoplasmic reticulum stress. Neurochem Int. 2010, 57: 588-599.","journal-title":"Neurochem Int"},{"issue":"2","key":"74_CR52","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1476-5381.2010.00656.x","volume":"160","author":"C Kurz","year":"2010","unstructured":"Kurz C, Ungerer I, Lipka U, Kirr S, Sch\u00fctt T, Eckert A, Leuner K, M\u00fcller WE: The metabolic enhancer piracetam ameliorates the impairment of mitochondrial function and neurite outgrowth induced by beta-amyloid peptide. Br J Pharmacol. 2010, 160 (2): 246-257.","journal-title":"Br J Pharmacol"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12929-014-0074-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-014-0074-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-014-0074-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-014-0074-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T05:16:03Z","timestamp":1630559763000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-014-0074-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,6]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["74"],"URL":"https:\/\/doi.org\/10.1186\/s12929-014-0074-2","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,6]]},"assertion":[{"value":"9 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"74"}}